Press Release Nissan Demonstrates Autonomous-Drive Mobility Services Progress on Public Roads 3 June 2024
Press Release Other World Computing Introduces Intel Thunderbolt Share for the Thunderbolt Go Dock 2 June 2024
Press Release New Blood Test Predicts Recurrence of Breast Cancer, Months or Even Years Before Relapse 2 June 2024
Press Release Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma 2 June 2024
Press Release TAGRISSO® (osimertinib) reduced the risk of disease progression or death by 84% in patients with unresectable, Stage III EGFR-mutated lung cancer vs. placebo in LAURA Phase III trial 2 June 2024
Press Release CatalYm Reports Impressive and Lasting Responses Including Multiple Complete Responses in Heavily Pretreated, Late- to Last-Line Metastatic NSCLC, Urothelial and Hepatocellular Cancer Patients Treated with Visugromab/Nivolumab Combination 2 June 2024
Press Release Belantamab Mafodotin combination reduced the risk of disease progression or death by nearly 50% versus standard of care combination in relapsed/refractory multiple myeloma 2 June 2024
Press Release Puma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041) 2 June 2024
Press Release Tempus Introduces New HER2 & FOLR1 Testing Solutions to Support Personalized Patient Care 2 June 2024
